(Q53275944)

12 May 2018

title

Biomarkers for the early diagnosis of Alzheimer's disease. (English)

1 reference

12 May 2018

1 reference

1

1 reference

12 May 2018

William E. Klunk

series ordinal

2

1 reference

12 May 2018

publication date

1 March 2006

1 reference

12 May 2018

published in

Lancet Neurology

1 reference

12 May 2018

volume

5

1 reference

12 May 2018

page(s)

198-199

1 reference

12 May 2018

issue

3

1 reference

12 May 2018

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970357-X

7 January 2021

Early marker for Alzheimer's disease: the atrophic hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970357-X

7 January 2021

Imaging cerebral atrophy: normal ageing to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970357-X

7 January 2021

Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970357-X

7 January 2021

MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970357-X

7 January 2021

Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970357-X

7 January 2021

Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970357-X

7 January 2021

Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970357-X

7 January 2021

Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970357-X

7 January 2021

Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970357-X

7 January 2021

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970357-X

7 January 2021

10.1016/S1474-4422(06)70357-X

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

16488371

1 reference

12 May 2018